Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-26 11:25 am Unchanged | 13G | CardioGenics Holdings Inc. CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | View |
2023-02-14 10:24 am Unchanged | 13G | CardioGenics Holdings Inc. CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | View |
2022-02-07 4:51 pm Unchanged | 13G | CardioGenics Holdings Inc. CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | View |
2021-01-22 2:43 pm Unchanged | 13G | CardioGenics Holdings Inc. CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | 0 (Unchanged) | View |
2020-01-16 12:18 pm Sale | 13G | CardioGenics Holdings Inc. CGNH | Iliad Research & Trading L.P. | 2,415,275 9.990% | -7,180,175 (-74.83%) | View |